The ECWM is an independent academic consortium dedicated to translational and clinical research in Waldenström‘s Macroglobulinemia.
Its mission is to improve understanding of the biology of WM and to develop therapies enabling patients to live a life without compromise, with the final goal to achieve cure.
The ECWM is a European network bringing together leading experts in Waldenström’s macroglobulinemia (WM) from across Europe.
The consortium connects clinicians and researchers to share expertise, foster collaboration, and advance research and clinical care in WM.
At the same time, the ECWM is committed to supporting patients by providing reliable information, raising awareness, and addressing the needs of people living with WM.
Together, the ECWM works towards better understanding, better treatment, and ultimately a cure for WM.
